发明名称 | Immunomodulatory compounds for the restoration of vitamin D sensitivity in vitamin D resistant tumor cells | ||
摘要 | Provided herein are methods of restoring vitamin D sensitivity in tumor cells that are vitamin D resistant. Also provided are methods of treating, preventing or managing cancer using an immunomodulatory compound in combination with a vitamin D agent. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed. | ||
申请公布号 | US8841325(B2) | 申请公布日期 | 2014.09.23 |
申请号 | US201013511002 | 申请日期 | 2010.11.24 |
申请人 | Celgene Corporation | 发明人 | Brosseau Carole;Bartlett Justin Blake;Dalgleish Angus George;Colston Kay Winifred;Galustian Christine |
分类号 | A61K31/45;C07D401/04 | 主分类号 | A61K31/45 |
代理机构 | Dorf & Nelson LLP | 代理人 | Dorf & Nelson LLP ;Locke, Esq. Scott D. |
主权项 | 1. A method of treating, managing or breast cancer refractory to vitamin D treatment, which comprises administering to a patient having such cancer an amount of an immunomodulatory compound, or a pharmaceutically acceptable salt, or stereoisomer thereof, in combination with a vitamin D agent, wherein the immunomodulatory compound is 4-(amino)-2-(2,6-dioxo-(3-piperidyl))-isoindoline-1,3-dione, or a pharmaceutically acceptable salt, or stereoisomer thereof, or 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl) -piperidine-2,6-dione, or a pharmaceutically acceptable salt, or stereoisomer thereof. | ||
地址 | Summit NJ US |